Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

32.86
Delayed Data
As of Sep 30
 -0.19 / -0.57%
Today’s Change
26.97
Today|||52-Week Range
35.04
-3.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues5.9B6.3B5.7B5.4B
 
 
 
 
 
Cost of Goods Sold444.9M512.1M400.3M436.2M
 
 
 
 
 
Depreciation And Amortization568.3M706.5M534.6M561.5M
 
 
 
 
 
 
Operating ExpensesGross Income4.9B5.1B4.8B4.4B
 
 
 
 
 
General Expenses4.0B4.1B3.7B4.1B
 
 
 
 
 
Other Operating Expenses55.7M0.000.000.00
 
 
Research And Development1.4B1.6B1.4B1.3B
 
 
 
 
 
Total Operating Expenses5.0B5.3B4.7B5.1B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income870.8M975.8M1.1B230.5M
 
 
 
 
 
Extraordinary Charge-213.0M-367.0M-290.3M-454.4M
 
 
 
 
 
Interest Expense On Debt244.8M288.1M147.5M151.1M
 
 
 
 
 
Equity In Earnings-2.0M-6.9M-3.8M-7.7M
 
 
 
 
 
Other Expenses515.5M464.7M51.7M353.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income928.6M798.2M683.1M-21.0M
 
 
 
 
 
Income Taxes-160.2M-5.9M-92.1M-956.6K
 
 
 
 
 
Minority Interest0.000.00-19.7M-26.8M
 
 
 
Net Income766.3M797.2M607.0M-2.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.30$0.31$0.24$0.00
 
 
 
 
EPS Diluted$0.30$0.32$0.24-$0.00